DPIIT recognised startup Government of India
Startup India
Satyarx Pharma Innovations Private Limited - healthcare in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹7.55 Cr
▲ 24% YoY
Net loss · FY 2025
₹1.84 Cr
Net margin -24.4%
EBITDA · FY 2025
-₹1 Cr
EBITDA margin -13.3%
Authorised capital
₹11 Cr
Registered with MCA
Paid-up capital
₹9.94 Cr
Issued & subscribed
Company age
6 yrs
Est. 2020
Employees · EPFO
47
Provident fund records
Directors on board
3
As per MCA filings
About Satyarx Pharma Innovations Private Limited
Data last updated:
Satyarx Pharma Innovations Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the oncology clinics and cancer treatment segment of the healthcare sector. It was incorporated on 08 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100TG2020PTC142629. Its GSTIN is 36ABECS1456J1Z6 (Telangana).
The company has an authorised share capital of ₹11 Cr and a paid-up capital of ₹9.94 Cr. It is led by directors including Ande Pratap Reddy and Satyanarayana Murthy Chavali.
Its last annual general meeting (AGM) was held on 20 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 3rd Floor Block B Cdc Towers Plot No. 10/8 Road No. 5 Nacharam Industrial Area, Hyderabad, Telangana, India – 500076.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.55 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net loss of ₹1.84 Cr (net margin -24.4%) and EBITDA of -₹1 Cr (EBITDA margin -13.3%). Revenue has declined at a compounded annual rate (CAGR) of 298% over three years and 2% over five years.
The company has about 47 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: SATYA Pharma Innovations.
Satyarx Pharma Innovations Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0009941). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website satyarx.com.
Company details
CIN U73100TG2020PTC142629
Registration Number 142629
Incorporation Date 08 August 2020
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 20 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Small
Udyam Registration UDYAM-TS-02-0009941
Recognitions & Rankings of Satyarx Pharma Innovations
MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-02-0009941
Contact details
Satyarx Pharma Innovations Private Limited's registered office is in Hyderabad, Telangana. Its website is satyarx.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address3rd Floor Block B Cdc Towers Plot No. 10/8 Road No. 5 Nacharam Industrial Area, Hyderabad, Telangana, India – 500076
- IndustryHealthcare, Oncology Clinics & Cancer Treatment
To see the full contact details of Satyarx Pharma Innovations Private Limited, buy the company report.
Comprehensive company report
Satyarx Pharma Innovations Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Satyarx Pharma Innovations operates one associated brand: SATYA Pharma Innovations. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops innovative small molecule technologies for cancer treatment. | satyarx.com |
Business activity
The main business activity of Satyarx Pharma Innovations is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Satyarx Pharma Innovations Private Limited, buy the company report.
Financials of Satyarx Pharma Innovations Private Limited
FY 2025 filings availableSatyarx Pharma Innovations Private Limited reported revenue of ₹7.55 Cr (up 24% YoY) for FY 2025.
Revenue · FY 2025
₹7.55 Cr ▲ 24%
Net loss · FY 2025
₹1.84 Cr margin -24.4%
EBITDA · FY 2025
-₹1 Cr margin -13.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 24%
3 years · compounded
▲ 298%
5 years · compounded
▼ 2%
EBITDA CAGR growth
1 year
▲ 82%
Revenue rose 24% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA rose 82% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.84 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -13.3% | ||||
| Net Profit Margin | -24.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Satyarx Pharma Innovations Private Limited, buy the company report.
Board of directors of Satyarx Pharma Innovations Private Limited
Satyarx Pharma Innovations has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ande Pratap Reddy | Director | 16 Nov 2020 | 5 Years 11 Months | Current |
| Satyanarayana Murthy Chavali | Director | 08 Aug 2020 | 6 Years 2 Months | Current |
| Saroja Chavali Also directs: Satyatx Pharma Services LLP, Shadkala Pharma India Private Limited | Director | 08 Aug 2020 | 6 Years 2 Months | Current |
Auditor
Satyarx Pharma Innovations Private Limited is audited by Bhanu Murali & Co for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Bhanu Murali & Co | FY 2024 | 014993S |
Shareholding
The shareholding of Satyarx Pharma Innovations Private Limited is on record for 4 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Satyarx Pharma Innovations Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Satyarx Pharma Innovations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Satyarx Pharma Innovations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Satyarx Pharma Innovations Private Limited has a workforce of 47 employees on its EPFO records as of May 22, 2025, across 1 active EPFO establishment.
Employee count
47
Active EPFO establishments
1
Employee growth
14.63%
GST
Satyarx Pharma Innovations has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36ABECS1456J1Z6 | Telangana | Active | 08 Aug 2020 |
To see the full GST registrations and return filing status of Satyarx Pharma Innovations Private Limited, buy the company report.
Recent activity
Satyarx Pharma Innovations Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Ande Pratap Reddy ceased to be Additional Director on 21 Oct 2021.
AGM
Satyarx Pharma Innovations Private Limited last Annual general meeting of members was held on 20 Sep 2025 as per latest MCA records.
Filing
Satyarx Pharma Innovations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Ande Pratap Reddy ceased to be Additional Director.
Appointed
Ande Pratap Reddy was appointed as Director.
Appointed
Saroja Chavali was appointed as Director.
Appointed
Satyanarayana Murthy Chavali was appointed as Director.
Incorporation
08 Aug 2020
Satyarx Pharma Innovations Private Limited was registered on 08 Aug 2020 with Roc Hyderabad & aged 6 years 3 months as per MCA records.
Frequently asked questions
Satyarx Pharma Innovations is an active private limited company based in Hyderabad, Telangana, India. The company works in oncology clinics and cancer treatment, within the healthcare industry. It was incorporated on 08 August 2020 (6+ years old) and is registered under CIN U73100TG2020PTC142629.
Satyarx Pharma Innovations has 3 current directors:
- Ande Pratap Reddy - Director
- Satyanarayana Murthy Chavali - Director
- Saroja Chavali - Director
The latest financial statements of Satyarx Pharma Innovations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 20 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Satyarx Pharma Innovations is 36ABECS1456J1Z6, registered in Telangana.
The CIN (Corporate Identification Number) of Satyarx Pharma Innovations is U73100TG2020PTC142629. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Satyarx Pharma Innovations was incorporated on 08 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
Ande Pratap Reddy ceased to be Additional Director on 21 Oct 2021. Ande Pratap Reddy was appointed as Director on 16 Nov 2020. Saroja Chavali was appointed as Director on 08 Aug 2020. Satyarx Pharma Innovations has 4 board changes on record in total.
Yes, Satyarx Pharma Innovations is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Satyarx Pharma Innovations is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0009941).
Satyarx Pharma Innovations can be reached through the website satyarx.com. Its registered office is in Hyderabad, Telangana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages